milatuzumabAgricultural BiotechnologyUpdated on Feb 9, 2020 View more like this | Visit SHIRLEY, NY | Contact Bella Smith |

Recombinant chimeric (primate/human) antibody expressed in CHO binding to human CD4/p55. Clenoliximab is a monoclonal antibody against CD4. It acts as an immunomodulator and has been investigated for the treatment of rheumatoid arthritis. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD74. Milatuzumab is a monoclonal antibody for the treatment of multiple myeloma and other hematological malignancies.